Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Breast Cancer

Free Subscription Articles published in Clin Breast Cancer Retrieve available abstracts of 156 articles: HTML format

Single Articles

September 2021
1. SAKACH E, O'Regan R, Meisel J, Li X, et al
   Molecular Classification of Triple Negative Breast Cancer and the Emergence of Targeted Therapies.
   Clin Breast Cancer. 2021 Sep 17. pii: S1526-8209(21)00261.
   PubMed     Abstract available
   
   
   
2. LI Y, Lin Q, Lu X, Li W, et al
   Post-Diagnosis use of Antioxidant Vitamin Supplements and Breast Cancer Prognosis: A Systematic Review and Meta-Analysis.
   Clin Breast Cancer. 2021 Sep 12. pii: S1526-8209(21)00259.
   PubMed     Abstract available
   
   
   
3. RAO MALLA R, Marni R, Kumari S, Chakraborty A, et al
   Microbiome Assisted Tumor Microenvironment: Emerging Target of Breast Cancer.
   Clin Breast Cancer. 2021 Sep 12. pii: S1526-8209(21)00260.
   PubMed     Abstract available
   
   
   August 2021
4. LI J, Li Y, Cheng H
   Circ-RPPH1 knockdown retards breast cancer progression via miR-328-3p-mediated suppression of HMGA2.
   Clin Breast Cancer. 2021 Aug 31. pii: S1526-8209(21)00247.
   PubMed     Abstract available
   
   
   
5. RIBATTI D, Annese T, Tamma R
   Controversial role of mast cells in breast cancer tumor progression and angiogenesis.
   Clin Breast Cancer. 2021 Aug 31. pii: S1526-8209(21)00246.
   PubMed     Abstract available
   
   
   
6. ZHU J, Zheng H, Ge C, Lin H, et al
   Competing Nomogram for Late-Period Breast Cancer-Specific Death in Patients with Early-Stage Hormone Receptor-Positive Breast Cancer.
   Clin Breast Cancer. 2021 Aug 31. pii: S1526-8209(21)00245.
   PubMed     Abstract available
   
   
   
7. SINCLAIR WD, Cui X
   The Effects of HER2 on CDK4/6 Activity in Breast Cancer.
   Clin Breast Cancer. 2021 Aug 26. pii: S1526-8209(21)00244.
   PubMed     Abstract available
   
   
   
8. ALMALKI HS, Lim A, Allen JC, Teo SY, et al
   Usefulness of supplementary ultrasound surveillance in the detection of a second breast cancer in patients with ductal carcinoma in situ.
   Clin Breast Cancer. 2021 Aug 20. pii: S1526-8209(21)00243.
   PubMed     Abstract available
   
   
   
9. LORUSSO P, Hamilton E, Ma C, Vidula N, et al
   A First-in-Human Phase 1 Study of a Novel Selective Androgen Receptor Modulator (SARM), RAD140, in ER+/HER2- Metastatic Breast Cancer.
   Clin Breast Cancer. 2021 Aug 20. pii: S1526-8209(21)00240.
   PubMed     Abstract available
   
   
   
10. BORMAN P, Yaman A, Yasrebi S, Pinar Inanli A, et al
    Combined Complete Decongestive Therapy Reduces Volume and Improves Quality of Life and Functional Status in Patients With Breast Cancer-Related Lymphedema.
    Clin Breast Cancer. 2021 Aug 19. pii: S1526-8209(21)00242.
    PubMed     Abstract available
    
    
    
11. KJOE PRLM, van der Wall E, Schagen SB
    Endocrine Therapy With or Without CDK4/6 Inhibitors in Women With Hormone-receptor Positive Breast Cancer: What do we Know About the Effects on Cognition?
    Clin Breast Cancer. 2021 Aug 14. pii: S1526-8209(21)00239.
    PubMed     Abstract available
    
    
    
12. GIANNI P, Matenoglou E, Geropoulos G, Agrawal N, et al
    The Fanconi anemia pathway and Breast Cancer: A comprehensive review of clinical data.
    Clin Breast Cancer. 2021 Aug 10. pii: S1526-8209(21)00238.
    PubMed     Abstract available
    
    
    
13. ZHANG S, Cui T, Duan Y, Zhang H, et al
    Radix Tetrastigma Extracts Enhance the Chemosensitivity in Triple-Negative Breast Cancer Via Inhibiting PI3K/Akt/mTOR-Mediated Autophagy.
    Clin Breast Cancer. 2021 Aug 4. pii: S1526-8209(21)00203.
    PubMed     Abstract available
    
    
    July 2021
14. LIU JK, Kaji AH, Roth KG, Hari DM, et al
    Determinants of Psychosocial Distress in Breast Cancer Patients at a Safety Net Hospital.
    Clin Breast Cancer. 2021 Jul 31. pii: S1526-8209(21)00172.
    PubMed     Abstract available
    
    
    
15. TOORANG F, Sasanfar B, Esmaillzadeh A, Zendehdel K, et al
    Adherence to the DASH Diet and Risk of Breast Cancer.
    Clin Breast Cancer. 2021 Jul 31. pii: S1526-8209(21)00198.
    PubMed     Abstract available
    
    
    
16. NORMAN H, Lee KT, Stearns V, Alcorn SR, et al
    Incidence and Severity of Myelosuppression With Palbociclib After Palliative Bone Radiation in Advanced Breast Cancer: A Single Center Experience and Review of Literature.
    Clin Breast Cancer. 2021 Jul 27. pii: S1526-8209(21)00202.
    PubMed     Abstract available
    
    
    
17. DE WILD SR, Simons JM, Vrancken Peeters MTFD, Smidt ML, et al
    MINImal vs. MAXimal Invasive Axillary Staging and Treatment After Neoadjuvant Systemic Therapy in Node Positive Breast Cancer: Protocol of a Dutch Multicenter Registry Study (MINIMAX).
    Clin Breast Cancer. 2021 Jul 26. pii: S1526-8209(21)00199.
    PubMed     Abstract available
    
    
    
18. DE MORAES CL, Cruz E Melo N, Valoyes MAV, Naves do Amaral W, et al
    AGR2 and AGR3 play an important role in the clinical characterization and prognosis of basal like breast cancer.
    Clin Breast Cancer. 2021 Jul 26. pii: S1526-8209(21)00196.
    PubMed     Abstract available
    
    
    
19. MOTOKI AH, Buttros DAB, Gaspar AL, Almeida-Filho BS, et al
    Association Between Metabolic Syndrome and Immunohistochemical Profile at Breast Cancer Diagnosis in Postmenopausal Women.
    Clin Breast Cancer. 2021 Jul 25. pii: S1526-8209(21)00197.
    PubMed     Abstract available
    
    
    
20. HAMMOND JB, Scott DW, Kosiorek HE, Parnall TH, et al
    Characterizing Occult Nodal Disease Within a Clinically Node-Negative, Neoadjuvant Breast Cancer Population.
    Clin Breast Cancer. 2021 Jul 25. pii: S1526-8209(21)00194.
    PubMed     Abstract available
    
    
    
21. CASTALDI M, James T
    Breast Cancer and the Male-Female Divide: It's Even More Complicated.
    Clin Breast Cancer. 2021 Jul 21. pii: S1526-8209(21)00139.
    PubMed    
    
    
    
22. YE F, Wen J, Yang A, Wang Y, et al
    The Influence of Hormone Therapy on secondary diabetes mellitus in Breast Cancer: A Meta-analysis.
    Clin Breast Cancer. 2021 Jul 21. pii: S1526-8209(21)00174.
    PubMed     Abstract available
    
    
    
23. WEINFURTNER RJ, Raghunand N, Stringfield O, Abdalah M, et al
    MRI Response to Pre-operative Stereotactic Ablative Body Radiotherapy (SABR) in Early Stage ER/PR+ HER2- Breast Cancer correlates with Surgical Pathology Tumor Bed Cellularity.
    Clin Breast Cancer. 2021 Jul 20. pii: S1526-8209(21)00177.
    PubMed     Abstract available
    
    
    
24. YOO GS, Kang D, Kim IR, Park H, et al
    Quantitative Changes in Skin Composition Parameters after Radiation Therapy According to Surgery Types Among Patients with Breast Cancer: A Prospective Study.
    Clin Breast Cancer. 2021 Jul 19. pii: S1526-8209(21)00175.
    PubMed     Abstract available
    
    
    
25. YADAV SK, Silwal S, Yadav S, Krishnamoorthy G, et al
    A Systematic Comparison of Overall Survival Between Men and Women With Triple Negative Breast Cancer.
    Clin Breast Cancer. 2021 Jul 18. pii: S1526-8209(21)00178.
    PubMed     Abstract available
    
    
    
26. FREBAULT J, Bergom C, Cortina CS, Shukla ME, et al
    Invasive Breast Cancer Treatment Patterns in Women Age 80 and Over: A Report from the National Cancer Database.
    Clin Breast Cancer. 2021 Jul 16. pii: S1526-8209(21)00193.
    PubMed     Abstract available
    
    
    
27. SIDDIQUI MF, Maalouf NM
    Impact of Incorporating Trabecular Bone Score Into Fracture Risk Assessment and Recommendation for Use of Bone-Modifying Agents in Women With Breast Cancer.
    Clin Breast Cancer. 2021 Jul 15. pii: S1526-8209(21)00181.
    PubMed    
    
    
    
28. REN T, Lin S, Huang P, Duong TQ, et al
    Convolutional Neural Network of Multiparametric MRI Accurately Detects Axillary Lymph Node Metastasis in Breast Cancer Patients With Pre Neoadjuvant Chemotherapy.
    Clin Breast Cancer. 2021 Jul 13. pii: S1526-8209(21)00179.
    PubMed     Abstract available
    
    
    
29. THOMIS S, Devoogdt N, De Vrieze T, Bechter-Hugl B, et al
    Relation Between Early Disturbance of lymphatic transport Visualized With Lymphofluoroscopy and Other Clinical Assessment Methods in Patients With Breast Cancer.
    Clin Breast Cancer. 2021 Jul 10. pii: S1526-8209(21)00176.
    PubMed     Abstract available
    
    
    
30. HAJI F, Hurvitz SA
    Can Women With HER2-Positive Metastatic Breast Cancer Be Cured?
    Clin Breast Cancer. 2021 Jul 3. pii: S1526-8209(21)00173.
    PubMed     Abstract available
    
    
    June 2021
31. JIANG Y, Xie Q, Chen R
    Breast Cancer Incidence and Mortality in Relation to Hormone Replacement Therapy Use Among Postmenopausal Women: Results From a Prospective Cohort Study.
    Clin Breast Cancer. 2021 Jun 26. pii: S1526-8209(21)00171.
    PubMed     Abstract available
    
    
    
32. LIU X, Liu M, Ma H, Wang J, et al
    miR-875 Serves as A Candidate Biomarker for Detection and Prognosis and Is Correlated with PHH3 Index Levels in Breast Cancer Patients.
    Clin Breast Cancer. 2021 Jun 23. pii: S1526-8209(21)00169.
    PubMed     Abstract available
    
    
    
33. LU JF, Hu ZQ, Yang MX, Liu WY, et al
    Downregulation of PDGF-D Inhibits Proliferation and Invasion in Breast Cancer MDA-MB-231 Cells.
    Clin Breast Cancer. 2021 Jun 23. pii: S1526-8209(21)00147.
    PubMed     Abstract available
    
    
    
34. SEKI H, Higeta K, Sakurai T, Sakurada A, et al
    Feasibility Study of Nanoparticle Albumin-Bound-Paclitaxel and S-1 Followed by Epirubicin/Cyclophosphamide as Neoadjuvant Chemotherapy in Patients With Operable Breast Cancer: A Prospective Study.
    Clin Breast Cancer. 2021 Jun 18. pii: S1526-8209(21)00152.
    PubMed     Abstract available
    
    
    
35. SHENOUDA M, Copley R, Pacioles T, Lebowicz Y, et al
    Effect of Tart Cherry on Aromatase Inhibitor-Induced Arthralgia (AIA) in Nonmetastatic Hormone-Positive Breast Cancer Patients: A Randomized Double-Blind Placebo-Controlled Trial.
    Clin Breast Cancer. 2021 Jun 18. pii: S1526-8209(21)00151.
    PubMed     Abstract available
    
    
    
36. CHEN M, Wu J, Liu D, Chen W, et al
    Combined Estrogen Receptor and Progesterone Receptor Level Can Predict Survival Outcome in Human Epidermal Growth Factor Receptor 2-positive Early Breast Cancer.
    Clin Breast Cancer. 2021 Jun 16. pii: S1526-8209(21)00140.
    PubMed     Abstract available
    
    
    
37. TOKUI R, Ishitobi M, Kurita T, Hatano T, et al
    A Comparison of the Oncological Outcomes After Breast-Conserving Surgery With or Without Latissimus Dorsi Myocutaneous Flap Reconstruction for Breast Cancer.
    Clin Breast Cancer. 2021 Jun 15. pii: S1526-8209(21)00150.
    PubMed     Abstract available
    
    
    
38. DONG L, Lin S, Zhong L, Nian D, et al
    Evaluation of Tucatinib in HER2-Positive Breast Cancer Patients With Brain Metastases: A United States-Based Cost-Effectiveness Analysis.
    Clin Breast Cancer. 2021 Jun 12. pii: S1526-8209(21)00146.
    PubMed     Abstract available
    
    
    
39. SCHLAFSTEIN A, Liu Y, Goyal S, Kahn S, et al
    Regional Nodal Irradiation for Clinically Node-Positive Breast Cancer Patients With Pathologic Negative Nodes After Neoadjuvant Chemotherapy.
    Clin Breast Cancer. 2021 Jun 12. pii: S1526-8209(21)00148.
    PubMed     Abstract available
    
    
    
40. OCCHIOGROSSO RH, Ren S, Tayob N, Li T, et al
    Feasibility of an Online Patient Community to Support Older Women With Newly Diagnosed Breast Cancer.
    Clin Breast Cancer. 2021 Jun 12. pii: S1526-8209(21)00149.
    PubMed     Abstract available
    
    
    
41. FALCONE V, Reiser E, Grula L, Bago-Horvath Z, et al
    Correlation Between Preoperative Radiological and Postoperative Pathological Tumor Size in Patients With HER2(+) Breast Cancer After Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab.
    Clin Breast Cancer. 2021 Jun 10. pii: S1526-8209(21)00145.
    PubMed     Abstract available
    
    
    
42. MO H, Jazieh KA, Brinzevich D, Abraham J, et al
    A Review of Treatment-Induced Pulmonary Toxicity in Breast Cancer.
    Clin Breast Cancer. 2021 Jun 10. pii: S1526-8209(21)00142.
    PubMed     Abstract available
    
    
    
43. CERNUSCO NLV, Bianco PD, Romano M, Muraglia A, et al
    Long-Term Outcomes Using Electron IOERT APBI for Early Stage Breast Cancer: The Verona University Hospital Experience.
    Clin Breast Cancer. 2021 Jun 10. pii: S1526-8209(21)00143.
    PubMed     Abstract available
    
    
    
44. BORTOLOZO HI, Derchain S, Vechin FC, Maginador GF, et al
    Aerobic Fitness is a Predictor of Body Composition in Women With Breast Cancer at Diagnosis.
    Clin Breast Cancer. 2021;21:e245-e251.
    PubMed     Abstract available
    
    
    
45. ANAND K, Niravath P, Patel T, Ensor J, et al
    A Phase II Study of the Efficacy and Safety of Chloroquine in Combination With Taxanes in the Treatment of Patients With Advanced or Metastatic Anthracycline-refractory Breast Cancer.
    Clin Breast Cancer. 2021;21:199-204.
    PubMed     Abstract available
    
    
    May 2021
46. HATZIPANAGIOTOU ME, Huber D, Gerthofer V, Hetterich M, et al
    Feasibility of ABUS as an Alternative to Handheld Ultrasound for Response Control in Neoadjuvant Breast Cancer Treatment.
    Clin Breast Cancer. 2021 May 26. pii: S1526-8209(21)00138.
    PubMed     Abstract available
    
    
    
47. SYMONDS L, Jenkins I, Linden HM, Kurland B, et al
    A Phase II Study Evaluating the Safety and Efficacy of Sunitinib Malate in Combination With Weekly Paclitaxel Followed by Doxorubicin and Daily Oral Cyclophosphamide Plus G-CSF as Neoadjuvant Chemotherapy for Locally Advanced or Inflammatory Breast Ca
    Clin Breast Cancer. 2021 May 24. pii: S1526-8209(21)00137.
    PubMed     Abstract available
    
    
    
48. MEYER C, Bailleux C, Chamorey E, Schiappa R, et al
    Factors Involved in Delaying Initiation of Adjuvant Chemotherapy After Breast Cancer Surgery.
    Clin Breast Cancer. 2021 May 24. pii: S1526-8209(21)00135.
    PubMed     Abstract available
    
    
    
49. HE X, Dai X, Ji J, Liu H, et al
    Nine-Year Median Follow-up of Ccardiotoxicity and Efficacy of Trastuzumab Concurrently With Anthracycline-Based and Anthracycline-Free Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer Patients.
    Clin Breast Cancer. 2021 May 24. pii: S1526-8209(21)00136.
    PubMed     Abstract available
    
    
    
50. DENG C, Xie Y, Liu Y, Li Y, et al
    Aromatherapy Plus Music Therapy Improve Pain Intensity and Anxiety Scores in Patients With Breast Cancer During Perioperative Periods: A Randomized Controlled Trial.
    Clin Breast Cancer. 2021 May 20. pii: S1526-8209(21)00134.
    PubMed     Abstract available
    
    
    
51. WANG M, Liu H, Wu W, Zhao J, et al
    Identification of Differentially Expressed Plasma lncRNAs As Potential Biomarkers for Breast Cancer.
    Clin Breast Cancer. 2021 May 18. pii: S1526-8209(21)00131.
    PubMed     Abstract available
    
    
    
52. MEMON R, Prieto Granada CN, Harada S, Winokur T, et al
    Discordance Between Immunohistochemistry and In Situ Hybridization to Detect HER2 Overexpression/Gene Amplification in Breast Cancer in the Modern Age: A Single Institution Experience and Pooled Literature Review Study: Discordance between HER2 overex
    Clin Breast Cancer. 2021 May 17. pii: S1526-8209(21)00132.
    PubMed     Abstract available
    
    
    
53. GUILLERM SO, Bourstyn E, Itti R, Cahen-Doidy L, et al
    Intraoperative Radiotherapy for Breast Cancer in Elderly Women.
    Clin Breast Cancer. 2021 May 15. pii: S1526-8209(21)00130.
    PubMed     Abstract available
    
    
    
54. HAMILTON EP, Kaklamani V, Falkson C, Vidal GA, et al
    Impact of Anti-HER2 Treatments Combined With Atezolizumab on the Tumor Immune Microenvironment in Early or Metastatic Breast Cancer: Results From a Phase Ib Study.
    Clin Breast Cancer. 2021 May 15. pii: S1526-8209(21)00089.
    PubMed     Abstract available
    
    
    
55. ZHOU J, Liu Y, Xu M, Mei L, et al
    Management of Breast Cancer Patients During the Coronavirus Disease 2019 Pandemic: The Experience From the Epicenter of China, Wuhan.
    Clin Breast Cancer. 2021 May 6. pii: S1526-8209(21)00114.
    PubMed     Abstract available
    
    
    
56. JI X, Li D, Gao D, Lv X, et al
    Value of Ultrasound-Guided Biopsy in Evaluating Internal Mammary Lymph Node Metastases in Breast Cancer.
    Clin Breast Cancer. 2021 May 6. pii: S1526-8209(21)00116.
    PubMed     Abstract available
    
    
    
57. TJOE JA, Heslin K, Perez Moreno AC, Thomas S, et al
    Factors Associated With Breast Cancer Surgery Delay Within a Coordinated Multihospital Community Health System: When Does Surgical Delay Impact Outcome?
    Clin Breast Cancer. 2021 May 3. pii: S1526-8209(21)00090.
    PubMed     Abstract available
    
    
    April 2021
58. JIA L, Ling Y, Li K, Zhang L, et al
    A 10-Gene Signature for Predicting the Response to Neoadjuvant Trastuzumab Therapy in HER2-Positive Breast Cancer.
    Clin Breast Cancer. 2021 Apr 29. pii: S1526-8209(21)00088.
    PubMed     Abstract available
    
    
    
59. SHAPIRO CL
    Bone-modifying Agents (BMAs) in Breast Cancer.
    Clin Breast Cancer. 2021 Apr 26. pii: S1526-8209(21)00087.
    PubMed     Abstract available
    
    
    
60. SHEIKHHOSSEIN F, Shab-Bidar S, Amini MR, Hosseini F, et al
    Dietary Insulin Index and Insulin Load in Relation to Breast Cancer: Findings from a Case-Control Study.
    Clin Breast Cancer. 2021 Apr 24. pii: S1526-8209(21)00086.
    PubMed     Abstract available
    
    
    
61. LEE Y, Kang E, Shin HC, Lee H, et al
    The Effect of Body Mass Index on Initial Breast Cancer Stage Among Korean Women.
    Clin Breast Cancer. 2021 Apr 22. pii: S1526-8209(21)00085.
    PubMed     Abstract available
    
    
    
62. WERUTSKY G, Reinert T, Rosa ML, Barrios CH, et al
    Real-world Data on First-line Systemic Therapy for Hormone Receptor-positive HER2-negative Metastatic Breast Cancer: A Trend Shift in the Era of CDK 4/6 Inhibitors.
    Clin Breast Cancer. 2021 Apr 20. pii: S1526-8209(21)00071.
    PubMed     Abstract available
    
    
    
63. VILLARREAL-GARZA C, Ferrigno AS, Mesa-Chavez F, Platas A, et al
    Improving Collection of Real-World Data: The Experience of the Joven & Fuerte Prospective Cohort for Mexican Young Women With Breast Cancer.
    Clin Breast Cancer. 2021 Apr 20. pii: S1526-8209(21)00083.
    PubMed     Abstract available
    
    
    
64. PANG J, Zhou H, Dong X, Wang S, et al
    Relationship Between the Neutrophil to Lymphocyte Ratio, Stromal Tumor-infiltrating Lymphocytes, and the Prognosis and Response to Neoadjuvant Chemotherapy in Triple-negative Breast Cancer.
    Clin Breast Cancer. 2021 Apr 14. pii: S1526-8209(21)00072.
    PubMed     Abstract available
    
    
    
65. ECE SOLMAZ A, Yeniay L, Gokmen E, Zekioglu O, et al
    Clinical Contribution of Next-Generation Sequencing Multigene Panel Testing for BRCA Negative High-Risk Patients With Breast Cancer.
    Clin Breast Cancer. 2021 Apr 12. pii: S1526-8209(21)00070.
    PubMed     Abstract available
    
    
    
66. LI X, Yan C, Xiao J, Xu X, et al
    Factors Associated With Surgical Modality Following Neoadjuvant Chemotherapy in Patients with Breast Cancer.
    Clin Breast Cancer. 2021 Apr 8. pii: S1526-8209(21)00066.
    PubMed     Abstract available
    
    
    
67. ARIF KMT, Bradshaw G, Nguyen TTN, Smith RA, et al
    Genetic Association Analysis Implicates Six MicroRNA-Related SNPs With Increased Risk of Breast Cancer in Australian Caucasian Women.
    Clin Breast Cancer. 2021 Apr 5. pii: S1526-8209(21)00067.
    PubMed     Abstract available
    
    
    
68. SILVA FR, Grande AJ, Lacerda Macedo AC, Colonetti T, et al
    Meta-Analysis of Breast Cancer Risk in Levonorgestrel-Releasing Intrauterine System Users.
    Clin Breast Cancer. 2021 Apr 3. pii: S1526-8209(21)00068.
    PubMed     Abstract available
    
    
    
69. WITT JS, Wisinski KB, Anderson BM
    Concurrent Radiation and Modern Systemic Therapies for Breast Cancer: An Ever-Expanding Frontier.
    Clin Breast Cancer. 2021;21:120-127.
    PubMed     Abstract available
    
    
    
70. CASEY DL, Gupta GP, Ollila DW
    The Role of Intraoperative Radiation in Early-stage Breast Cancer.
    Clin Breast Cancer. 2021;21:103-111.
    PubMed     Abstract available
    
    
    March 2021
71. REINERT T, de Souza ABA, Rosa ML, Bedin SR, et al
    Perspectives on the Systemic Staging in Newly Diagnosed Breast Cancer.
    Clin Breast Cancer. 2021 Mar 27. pii: S1526-8209(21)00065.
    PubMed     Abstract available
    
    
    
72. MCEVOY MP, Ravetch E, Patel G, Fox J, et al
    Prevention of Breast Cancer-Related Lymphedema.
    Clin Breast Cancer. 2021 Mar 17. pii: S1526-8209(21)00051.
    PubMed     Abstract available
    
    
    
73. NGUYEN AT, Shiao SL, McArthur HL
    Advances in Combining Radiation and Immunotherapy in Breast Cancer.
    Clin Breast Cancer. 2021 Mar 16. pii: S1526-8209(21)00062.
    PubMed     Abstract available
    
    
    
74. HALEY B, Batra K, Sahoo S, Froehlich T, et al
    A Phase I/Ib Trial of PD 0332991 (Palbociclib) and T-DM1 in HER2-Positive Advanced Breast Cancer After Trastuzumab and Taxane Therapy.
    Clin Breast Cancer. 2021 Mar 11. pii: S1526-8209(21)00060.
    PubMed     Abstract available
    
    
    
75. JOY AA, Vos LJ, Pituskin E, Cook SF, et al
    Uridine Glucuronosyltransferase 2B7 Polymorphism-Based Pharmacogenetic Dosing of Epirubicin in FEC Chemotherapy for Early-Stage Breast Cancer.
    Clin Breast Cancer. 2021 Mar 6. pii: S1526-8209(21)00056.
    PubMed     Abstract available
    
    
    
76. LEE E, Tweed C, Mylander C, Martino L, et al
    The Impact of Genomic Profiling on Adjuvant Therapy Recommendation in Postmenopausal Women with ER-Positive, T1-2 Breast Cancer: Can Genomic Profiling Eliminate the Need for Sentinel Lymph Node Biopsy?
    Clin Breast Cancer. 2021 Mar 4. pii: S1526-8209(21)00053.
    PubMed     Abstract available
    
    
    February 2021
77. KOZAK MM, von Eyben R, Gutkin PM, Vemuri M, et al
    Locoregional and Distant Outcomes in Women With cT1-3N1 Breast Cancer Treated With Neoadjuvant Chemotherapy With or Without Adjuvant Radiotherapy.
    Clin Breast Cancer. 2021 Feb 26. pii: S1526-8209(21)00050.
    PubMed     Abstract available
    
    
    
78. SALVATORE S, Nappi RE, Casiraghi A, Ruffolo AF, et al
    Microablative Fractional CO2 Laser for Vulvovaginal Atrophy in Women With a History of Breast Cancer: A Pilot Study at 4-week Follow-up.
    Clin Breast Cancer. 2021 Feb 23. pii: S1526-8209(21)00007.
    PubMed     Abstract available
    
    
    
79. GURU SD, Hoskin TL, Whaley DH, Nathan MA, et al
    Repeat Sentinel Lymph Node Surgery in Recurrent Breast Cancer: Peritumoral vs. Periareolar Injections.
    Clin Breast Cancer. 2021 Feb 18. pii: S1526-8209(21)00046.
    PubMed     Abstract available
    
    
    
80. LEE SJ, Lee J, Jung JH, Park HY, et al
    Exosomal Del-1 as a Potent Diagnostic Marker for Breast Cancer: Prospective Cohort Study.
    Clin Breast Cancer. 2021 Feb 17. pii: S1526-8209(21)00044.
    PubMed     Abstract available
    
    
    
81. MA S, Guo C, Sun C, Han T, et al
    Aspirin Use and Risk of Breast Cancer: A Meta-analysis of Observational Studies from 1989 to 2019.
    Clin Breast Cancer. 2021 Feb 17. pii: S1526-8209(21)00047.
    PubMed     Abstract available
    
    
    
82. BOUZIDI L, Triki H, Charfi S, Kridis WB, et al
    Prognostic Value of Natural Killer Cells Besides Tumor-Infiltrating Lymphocytes in Breast Cancer Tissues.
    Clin Breast Cancer. 2021 Feb 16. pii: S1526-8209(21)00045.
    PubMed     Abstract available
    
    
    
83. JACKISCH C, Barcenas CH, Bartsch R, Palma JD, et al
    Optimal Strategies for Successful Initiation of Neratinib in Patients with HER2-Positive Breast Cancer.
    Clin Breast Cancer. 2021 Feb 6. pii: S1526-8209(21)00043.
    PubMed     Abstract available
    
    
    
84. HUANG X, Lin S, Rao X, Zeng D, et al
    First-line Treatment with Ribociclib plus Endocrine Therapy for Premenopausal Women with Hormone-receptor-positive Advanced Breast Cancer: A Cost-effectiveness Analysis.
    Clin Breast Cancer. 2021 Feb 4. pii: S1526-8209(21)00041.
    PubMed     Abstract available
    
    
    
85. TESFAW A, Getachew S, Addissie A, Jemal A, et al
    Late-Stage Diagnosis and Associated Factors Among Breast Cancer Patients in South and Southwest Ethiopia: A Multicenter Study.
    Clin Breast Cancer. 2021;21:e112-e119.
    PubMed     Abstract available
    
    
    
86. SEFIDBAKHT S, Askarian M, Bijan B, Eghtedari M, et al
    Resuming Breast Imaging Services in the Aftermath of the COVID-19 Pandemic: Safety and Beyond.
    Clin Breast Cancer. 2021;21:e136-e140.
    PubMed     Abstract available
    
    
    
87. TAKASHIMA T, Hara F, Iwamoto T, Uemura Y, et al
    A Correlation Analysis Between Metabolism-related Genes and Treatment Response to S-1 as First-line Chemotherapy for Metastatic Breast Cancer: The SELECT BC-EURECA Study.
    Clin Breast Cancer. 2021 Feb 1. pii: S1526-8209(21)00040.
    PubMed     Abstract available
    
    
    
88. CAZZANIGA ME, Giordano M, Bandera M, Cassani C, et al
    Managing Menopausal Symptoms in Young Women With Breast Cancer: When Medicine Is Not All. The Take Care Project.
    Clin Breast Cancer. 2021 Feb 1. pii: S1526-8209(21)00022.
    PubMed     Abstract available
    
    
    January 2021
89. DAILY K, Douglas E, Romitti PA, Thomas A, et al
    Epidemiology of De Novo Metastatic Breast Cancer.
    Clin Breast Cancer. 2021 Jan 31. pii: S1526-8209(21)00029.
    PubMed     Abstract available
    
    
    
90. AGGARWAL A, Adepoju B, Yacur M, Maron D, et al
    Gender Disparity in Breast Cancer: A Veteran Population-Based Comparison.
    Clin Breast Cancer. 2021 Jan 26. pii: S1526-8209(21)00026.
    PubMed     Abstract available
    
    
    
91. WU J, Zhou Z
    MicroRNA-432 Acts as a Prognostic Biomarker and an Inhibitor of Cell Proliferation, Migration, and Invasion in Breast Cancer.
    Clin Breast Cancer. 2021 Jan 23. pii: S1526-8209(21)00025.
    PubMed     Abstract available
    
    
    
92. ANOOP TM, Joseph P R, Pn M, Kp P, et al
    Cutaneous Toxicities in Breast Cancer Patients Receiving Chemotherapy and Targeted Agents--An Observational Clinical Study.
    Clin Breast Cancer. 2021 Jan 23. pii: S1526-8209(21)00021.
    PubMed     Abstract available
    
    
    
93. LIN J, Guo Z, Wang S, Zheng X, et al
    Omission of Chemotherapy in HR+/HER2- Early Invasive Breast Cancer Based on Combined 6-IHC Score?
    Clin Breast Cancer. 2021 Jan 23. pii: S1526-8209(21)00023.
    PubMed     Abstract available
    
    
    
94. SHARMA RD, Sharmin A, Sinha A, Solomon A, et al
    Is it Possible to Predict Non Sentinel Node Positivity on the Basis of mRNA Copy Numbers of CK19 Receptor in Breast Cancer?
    Clin Breast Cancer. 2021 Jan 23. pii: S1526-8209(21)00024.
    PubMed     Abstract available
    
    
    
95. WEI G, Kumar A, Lee MC, Wang X, et al
    Influential Factors on Risk-reduction Mastectomy in a High-risk Breast Cancer Population With Genetic Predispositions.
    Clin Breast Cancer. 2021 Jan 19. pii: S1526-8209(21)00020.
    PubMed     Abstract available
    
    
    
96. LAILLER G, Memoli V, Le Bihan Benjamin C, Ben Diane MK, et al
    Five-Year Adjuvant Endocrine Therapy Adherence Trajectories Among Women With Breast Cancer: A Nationwide French Study Using Administrative Data.
    Clin Breast Cancer. 2021 Jan 13. pii: S1526-8209(21)00019.
    PubMed     Abstract available
    
    
    
97. MARTIN HUERTAS R, Fernandez Abad M, Corral de la Fuente E, Serrano Domingo JJ, et al
    Prolonged Responses With Trastuzumab Emtasine Treatment of Human Epidermal Growth Factor Receptor 2-positive Metastatic Breast Cancer Refractory to Trastuzumab and Pertuzumab: Systematic Review of Evidence.
    Clin Breast Cancer. 2021 Jan 7. pii: S1526-8209(21)00005.
    PubMed     Abstract available
    
    
    
98. PADMALATHA S, Tsai YT, Ku HC, Wu YL, et al
    Higher Risk of Depression After Total Mastectomy Versus Breast Reconstruction Among Adult Women With Breast Cancer: A Systematic Review and Metaregression.
    Clin Breast Cancer. 2021 Jan 7. pii: S1526-8209(21)00004.
    PubMed     Abstract available
    
    
    
99. KIM HK, Lee HS, Heo MH, Kim JY, et al
    Ventriculoperitoneal Shunt for CNS Metastasis in Breast Cancer: Clinical Outcomes Based on Intrinsic Subtype.
    Clin Breast Cancer. 2021 Jan 6. pii: S1526-8209(21)00001.
    PubMed     Abstract available
    
    
    
100. CHEN P, Chen R, Guo H, Cheng J, et al
     CASC15 Polymorphisms are Correlated With Breast Cancer Susceptibility in Chinese Han Women.
     Clin Breast Cancer. 2021 Jan 6. pii: S1526-8209(21)00006.
     PubMed     Abstract available
     
     
     
101. VIDAL GA, Carter GC, Gilligan AM, Saverno K, et al
     Development of a Prognostic Factor Index Among Women With HR(+)/HER2(-) Metastatic Breast Cancer in a Community Oncology Setting.
     Clin Breast Cancer. 2021 Jan 1. pii: S1526-8209(20)30340.
     PubMed     Abstract available
     
     
     December 2020
102. BRYCE Y, Bourguillon R, Vazquez JC, Ziv E, et al
     Prevalence, Outcome, and Management of Risk Factors in Patients With Breast Cancer With Peripheral Arterial Disease: A Tertiary Cancer Center's Experience.
     Clin Breast Cancer. 2020 Dec 30. pii: S1526-8209(20)30338.
     PubMed     Abstract available
     
     
     
103. MAHTANI R, Kittaneh M, Kalinsky K, Mamounas E, et al
     Advances in Therapeutic Approaches for Triple-Negative Breast Cancer.
     Clin Breast Cancer. 2020 Dec 29. pii: S1526-8209(20)30339.
     PubMed     Abstract available
     
     
     
104. ZHAO RP, Li Z, Li C, Xu K, et al
     A Genetic Variant of the BTLA Gene is Related to Increased Risk and Clinical Manifestations of Breast Cancer in Chinese Women.
     Clin Breast Cancer. 2020 Dec 28. pii: S1526-8209(20)30337.
     PubMed     Abstract available
     
     
     
105. XU N, Zhou J, He X, Ye S, et al
     Radiomics Model for Evaluating the Level of Tumor-Infiltrating Lymphocytes in Breast Cancer Based on Dynamic Contrast-Enhanced MRI.
     Clin Breast Cancer. 2020 Dec 28. pii: S1526-8209(20)30336.
     PubMed     Abstract available
     
     
     
106. FERNANDES LE, Epstein CG, Bobe AM, Bell JSK, et al
     Real-world Evidence of Diagnostic Testing and Treatment Patterns in US Patients With Breast Cancer With Implications for Treatment Biomarkers From RNA Sequencing Data.
     Clin Breast Cancer. 2020 Dec 18. pii: S1526-8209(20)30296.
     PubMed     Abstract available
     
     
     
107. SAGONA A, Gentile D, Anghelone CAP, Barbieri E, et al
     Ipsilateral Breast Cancer Recurrence: Characteristics, Treatment, and Long-Term Oncologic Results at a High-Volume Center.
     Clin Breast Cancer. 2020 Dec 17. pii: S1526-8209(20)30334.
     PubMed     Abstract available
     
     
     
108. HUANG X, Mai J, Huang Y, He L, et al
     Radiomic Nomogram for Pretreatment Prediction of Pathologic Complete Response to Neoadjuvant Therapy in Breast Cancer: Predictive Value of Staging Contrast-enhanced CT.
     Clin Breast Cancer. 2020 Dec 17. pii: S1526-8209(20)30332.
     PubMed     Abstract available
     
     
     
109. BALASUBRAMANIAN I, Harding T, Boland MR, Ryan EJ, et al
     The Impact of Postoperative Wound Complications on Oncological Outcomes Following Immediate Breast Reconstruction for Breast Cancer: A Meta-analysis.
     Clin Breast Cancer. 2020 Dec 17. pii: S1526-8209(20)30333.
     PubMed     Abstract available
     
     
     
110. CHEN X, Wang J, Fan Y, Luo Y, et al
     Primary Trastuzumab Resistance After (Neo)adjuvant Trastuzumab-containing Treatment for Patients With HER2-positive Breast Cancer in Real-world Practice.
     Clin Breast Cancer. 2020 Dec 16. pii: S1526-8209(20)30218.
     PubMed     Abstract available
     
     
     
111. SATO J, Azuma K, Kinowaki K, Ikeda K, et al
     Combined Use of Immunoreactivities of RIG-I with Efp/TRIM25 for Predicting Prognosis of Patients With Estrogen Receptor-positive Breast Cancer.
     Clin Breast Cancer. 2020 Dec 9. pii: S1526-8209(20)30328.
     PubMed     Abstract available
     
     
     
112. AL-SALEH K, Aldiab A, Salah T, Arafah M, et al
     Prognostic Significance of HER2 Expression Changes Following Neoadjuvant Chemotherapy in Saudi Patients With Locally Advanced Breast Cancer.
     Clin Breast Cancer. 2020 Dec 3. pii: S1526-8209(20)30324.
     PubMed     Abstract available
     
     
     
113. CALI DAYLAN AE, Leone JP
     Targeted Therapies for Breast Cancer Brain Metastases.
     Clin Breast Cancer. 2020 Dec 1. pii: S1526-8209(20)30323.
     PubMed     Abstract available
     
     
     
114. AMMAD UD DIN M, Jamshed S, Patel M
     Use of Immune Checkpoint Inhibitors in Early Triple-Negative Breast Cancer: Beyond the Early Conflicting Results.
     Clin Breast Cancer. 2020 Dec 1. pii: S1526-8209(20)30325.
     PubMed    
     
     
     November 2020
115. SHATNAWI A, Ayoub NM, Alkhalifa AE
     ING4 Expression Landscape and Association With Clinicopathologic Characteristics in Breast Cancer.
     Clin Breast Cancer. 2020 Nov 19. pii: S1526-8209(20)30295.
     PubMed     Abstract available
     
     
     
116. SANNA G, Pestrin M, Moretti E, Biagioni C, et al
     A Dose-finding Study of Metronomic Oral Vinorelbine in Combination With Oral Cyclophosphamide and Bevacizumab in Patients With Advanced Breast Cancer.
     Clin Breast Cancer. 2020 Nov 19. pii: S1526-8209(20)30294.
     PubMed     Abstract available
     
     
     
117. MANLEY H, Mutasa S, Chang P, Desperito E, et al
     Dynamic Changes of Convolutional Neural Network-based Mammographic Breast Cancer Risk Score Among Women Undergoing Chemoprevention Treatment.
     Clin Breast Cancer. 2020 Nov 17. pii: S1526-8209(20)30291.
     PubMed     Abstract available
     
     
     
118. MURATA T, Watase C, Shiino S, Jimbo K, et al
     Development and Validation of a Preoperative Scoring System to Distinguish Between Nonadvanced and Advanced Axillary Lymph Node Metastasis in Patients With Early-stage Breast Cancer.
     Clin Breast Cancer. 2020 Nov 17. pii: S1526-8209(20)30292.
     PubMed     Abstract available
     
     
     
119. GILBERT A, Williams C, Azuero A, Burkard ME, et al
     Utilizing Data Visualization to Identify Survival and Treatment Differences Between Women With De Novo and Recurrent Metastatic Breast Cancer.
     Clin Breast Cancer. 2020 Nov 17. pii: S1526-8209(20)30293.
     PubMed     Abstract available
     
     
     
120. HAN Y, Wang J, Sun Y, Yu P, et al
     Prognostic Model and Nomogram for Estimating Survival of Small Breast Cancer: A SEER-based Analysis.
     Clin Breast Cancer. 2020 Nov 13. pii: S1526-8209(20)30290.
     PubMed     Abstract available
     
     
     
121. FAHIM HH, Mohamed G, Safwat G, Abo-Bakr A, et al
     HSP70 as a Diagnostic and Prognostic Marker in Egyptian Women With Breast Cancer.
     Clin Breast Cancer. 2020 Nov 13. pii: S1526-8209(20)30289.
     PubMed     Abstract available
     
     
     
122. KOZAR N, Kruusmaa K, Bitenc M, Argamasilla R, et al
     Identification of Novel Diagnostic Biomarkers in Breast Cancer Using Targeted Metabolomic Profiling.
     Clin Breast Cancer. 2020 Nov 11. pii: S1526-8209(20)30232.
     PubMed     Abstract available
     
     
     
123. KOPETTI C, Schaffer C, Zaman K, Liapi A, et al
     Invasive Breast Cancer in a Trans Man After Bilateral Mastectomy: Case Report and Literature Review.
     Clin Breast Cancer. 2020 Nov 10. pii: S1526-8209(20)30264.
     PubMed    
     
     
     
124. LA VERDE N, Collova E, Blasi L, Pinotti G, et al
     Overall Survival in Metastatic Breast Cancer Patients in the Third Millennium: Results of the COSMO Study.
     Clin Breast Cancer. 2020 Nov 9. pii: S1526-8209(20)30272.
     PubMed     Abstract available
     
     
     
125. FORTUNATO L, d'Amati G, Taffurelli M, Tinterri C, et al
     Severe Impact of Covid-19 Pandemic on Breast Cancer Care in Italy: A Senonetwork National Survey.
     Clin Breast Cancer. 2020 Nov 2. pii: S1526-8209(20)30271.
     PubMed    
     
     
     October 2020
126. KORUCU TS, Ucurum SG, Tastaban E, Ozgun H, et al
     Comparison of Shoulder-Arm Complex Pain, Function, and Scapular Dyskinesia in Women With and Without Unilateral Lymphedema After Breast Cancer Surgery.
     Clin Breast Cancer. 2020 Oct 29. pii: S1526-8209(20)30267.
     PubMed     Abstract available
     
     
     
127. BRENES SANCHEZ JM, Picado AL, Olivares Crespo ME, Garcia Saenz JA, et al
     Breast Cancer Management During COVID-19 Pandemic in Madrid: Surgical Strategy.
     Clin Breast Cancer. 2020 Oct 24. pii: S1526-8209(20)30265.
     PubMed     Abstract available
     
     
     
128. TAKALA L, Kuusinen TE, Skytta T, Kellokumpu-Lehtinen PL, et al
     Electronic Patient-reported Outcomes During Breast Cancer Adjuvant Radiotherapy.
     Clin Breast Cancer. 2020 Oct 20. pii: S1526-8209(20)30263.
     PubMed     Abstract available
     
     
     
129. STRIGEL RM, Bravo E, Tevaarwerk AJ, Anderson BM, et al
     Development and Implementation of an Algorithm to Guide MRI Screening in Patients With a Personal History of Treated Breast Cancer.
     Clin Breast Cancer. 2020 Oct 17. pii: S1526-8209(20)30021.
     PubMed     Abstract available
     
     
     
130. YANG W, He X, He C, Peng L, et al
     Impact of ESR1 Polymorphisms on Risk of Breast Cancer in the Chinese Han Population.
     Clin Breast Cancer. 2020 Oct 16. pii: S1526-8209(20)30262.
     PubMed     Abstract available
     
     
     
131. BOSE S, Kalinsky K
     Durable Clinical Activity to the AKT Inhibitor Ipatasertib in a Heavily Pretreated Patient With an AKT1 E17K Mutant Metastatic Breast Cancer.
     Clin Breast Cancer. 2020 Oct 14. pii: S1526-8209(20)30261.
     PubMed    
     
     
     
132. CHAN A, Moy B, Mansi J, Ejlertsen B, et al
     Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET Trial.
     Clin Breast Cancer. 2020 Oct 6. pii: S1526-8209(20)30258.
     PubMed     Abstract available
     
     
     
133. LOH ZJ, Wu TY, Cheng FT
     Evaluation of the Learning Curve in Robotic Nipple-sparing Mastectomy for Breast Cancer.
     Clin Breast Cancer. 2020 Oct 3. pii: S1526-8209(20)30257.
     PubMed     Abstract available
     
     
     
134. SAMUEL EZIOKWU A, Varella L, Lynn Kruse M, Jia X, et al
     Real-world Outcomes of Cyclin-dependent Kinase Inhibitors Continued Beyond First Disease Progression in Hormone Receptor-positive Metastatic Breast Cancer.
     Clin Breast Cancer. 2020 Oct 2. pii: S1526-8209(20)30254.
     PubMed     Abstract available
     
     
     September 2020
135. HAMILTON E, Cortes J, Ozyilkan O, Chen SC, et al
     nextMONARCH: Abemaciclib Monotherapy or Combined With Tamoxifen for Metastatic Breast Cancer.
     Clin Breast Cancer. 2020 Sep 30. pii: S1526-8209(20)30255.
     PubMed     Abstract available
     
     
     
136. GOEL AK, Zamre V, Sharma G, Singh D, et al
     Immunohistochemical Markers as a Surrogate Method for Differentiation of Luminal Subtypes of Breast Cancer and Their Prognostic Significance.
     Clin Breast Cancer. 2020 Sep 28. pii: S1526-8209(20)30182.
     PubMed    
     
     
     
137. AGHAMOHAMMADI V, Salari-Moghaddam A, Benisi-Kohansal S, Taghavi M, et al
     Adherence to the MIND Diet and Risk of Breast Cancer: A Case-control Study.
     Clin Breast Cancer. 2020 Sep 24. pii: S1526-8209(20)30253.
     PubMed     Abstract available
     
     
     
138. HAYASHI N, Yagata H, Tsugawa K, Kajiura Y, et al
     Response and Prognosis of Docetaxel and Cyclophosphamide as Neoadjuvant Chemotherapy in ER(+) HER2(-) Breast Cancer: A Prospective Phase II Study.
     Clin Breast Cancer. 2020 Sep 18. pii: S1526-8209(20)30233.
     PubMed     Abstract available
     
     
     
139. DUAN X, Liu X, Cao Y, Li Y, et al
     Effect of MicroRNA-766 Promotes Proliferation, Chemoresistance, Migration, and Invasion of Breast Cancer Cells.
     Clin Breast Cancer. 2020 Sep 18. pii: S1526-8209(19)30720.
     PubMed     Abstract available
     
     
     
140. MORANTE Z, Ruiz R, Araujo JM, Pinto JA, et al
     Impact of the Delayed Initiation of Adjuvant Chemotherapy in the Outcome of Triple Negative Breast Cancer.
     Clin Breast Cancer. 2020 Sep 18. pii: S1526-8209(20)30235.
     PubMed     Abstract available
     
     
     
141. DE SANCTIS V, Alfo M, Vitiello C, Vullo G, et al
     Markers of Cardiotoxicity in Early Breast Cancer Patients Treated With a Hypofractionated Schedule: A Prospective Study.
     Clin Breast Cancer. 2020 Sep 10. pii: S1526-8209(20)30220.
     PubMed     Abstract available
     
     
     
142. FRANCESCHINI D, Loi M, Chiola I, Arculeo S, et al
     Preliminary Results of a Randomized Study on Postmenopausal Women With Early Stage Breast Cancer: Adjuvant Hypofractionated Whole Breast Irradiation Versus Accelerated Partial Breast Irradiation (HYPAB Trial).
     Clin Breast Cancer. 2020 Sep 9. pii: S1526-8209(20)30219.
     PubMed     Abstract available
     
     
     
143. COCO S, Boccardo S, Mora M, Fontana V, et al
     Radiation-Related Deregulation of TUBB3 and BRCA1/2 and Risk of Secondary Lung Cancer in Women With Breast Cancer.
     Clin Breast Cancer. 2020 Sep 6. pii: S1526-8209(20)30216.
     PubMed     Abstract available
     
     
     
144. CIURO J, Beyer A, Fritzler J, Jackson N, et al
     Health Care Disparities and Demand for Expanding Hereditary Breast Cancer Screening Guidelines in African Americans.
     Clin Breast Cancer. 2020 Sep 3. pii: S1526-8209(20)30215.
     PubMed     Abstract available
     
     
     August 2020
145. SHAH OS, Soran A, Sahin M, Knapick BA, et al
     Identifying Genomic Alterations in Patients With Stage IV Breast Cancer Using MammaSeq: An International Collaborative Study.
     Clin Breast Cancer. 2020 Aug 20. pii: S1526-8209(20)30213.
     PubMed     Abstract available
     
     
     July 2020
146. JAMES J, Teo M, Ramachandran V, Law M, et al
     Looking for Metastasis in Early Breast Cancer: Does Bone Scan Help? A Retrospective Review.
     Clin Breast Cancer. 2020 Jul 8. pii: S1526-8209(20)30170.
     PubMed     Abstract available
     
     
     April 2020
147. GUILLAUME Z, Medioni J, Lillo-Lelouet A, Marret G, et al
     Severe Cellular Immunodeficiency Triggered by the CDK4/6 Inhibitor Palbociclib.
     Clin Breast Cancer. 2020;20:e192-e195.
     PubMed    
     
     
     
148. FOUNTZILAS E, Konstantopoulou I, Vagena A, Apostolou P, et al
     Pathology of BRCA1- and BRCA2-associated Breast Cancers: Known and Less Known Connections.
     Clin Breast Cancer. 2020;20:152-159.
     PubMed     Abstract available
     
     
     
149. TU CW, Fang CL, Tsai CB, Hsu CH, et al
     Breast Reconstruction After Resection of Bilateral Giant Phyllodes Tumors: Two Separate Deep Inferior Epigastric Perforator Flaps From One Donor Site.
     Clin Breast Cancer. 2020;20:e188-e191.
     PubMed    
     
     
     
150. CUTULI B, Lemanski C, De Lafontan B, Chauvet MP, et al
     Ductal Carcinoma in Situ: A French National Survey. Analysis of 2125 Patients.
     Clin Breast Cancer. 2020;20:e164-e172.
     PubMed     Abstract available
     
     
     
151. CASASANTA N, Kipnis ST, Linville L, Lipinski S, et al
     Relationship Between Hereditary Cancer Syndromes and Oncotype DX Recurrence Score.
     Clin Breast Cancer. 2020;20:125-130.
     PubMed     Abstract available
     
     
     February 2020
152. BURKE EE, Laronga C, Sun W, DeBiase S, et al
     Implant-sparing Mastectomy: An Alternative for Women Undergoing Mastectomy With Retropectoral Implants.
     Clin Breast Cancer. 2020;20:e14-e19.
     PubMed     Abstract available
     
     
     
153. AYDOGAN T, Sezgin E, Ilvan S, Yilmaz OC, et al
     Comparison of Radio-guided Occult Lesion Localization (ROLL) and Magnetic Occult Lesion Localization (MOLL) for Non-palpable Lesions: A Phantom Model Study.
     Clin Breast Cancer. 2020;20:e9-e13.
     PubMed     Abstract available
     
     
     
154. SHUI R, Liang X, Li X, Liu Y, et al
     Hormone Receptor and Human Epidermal Growth Factor Receptor 2 Detection in Invasive Breast Carcinoma: A Retrospective Study of 12,467 Patients From 19 Chinese Representative Clinical Centers.
     Clin Breast Cancer. 2020;20:e65-e74.
     PubMed     Abstract available
     
     
     
155. ROBERTSON SJ, Pond GR, Hilton J, Petkiewicz SL, et al
     Selecting Patients for Oncotype DX Testing Using Standard Clinicopathologic Information.
     Clin Breast Cancer. 2020;20:61-67.
     PubMed     Abstract available
     
     
     
156. FUSHIMI A, Kudo R, Takeyama H
     Do Decreased Breast Microcalcifications After Neoadjuvant Chemotherapy Predict Pathologic Complete Response?
     Clin Breast Cancer. 2020;20:e82-e88.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: